Compounds > glycerylphosphorylcholine
Page last updated: 2024-08-21

glycerylphosphorylcholine and Idiopathic Parkinson Disease

glycerylphosphorylcholine has been researched along with Idiopathic Parkinson Disease in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Anikina, MA; Batukaeva, LA; Iunishchenko, NA; Levin, OS1
Blusztajn, JK; Growdon, JH; Nitsch, RM; Pittas, AG; Slack, BE; Wurtman, RJ1

Trials

1 trial(s) available for glycerylphosphorylcholine and Idiopathic Parkinson Disease

ArticleYear
[Efficacy and tolerability of choline alphoscerate (cereton) in patients with Parkinson's disease with cognitive disorders].
    Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova, 2009, Volume: 109, Issue:11

    Topics: Cognition; Cognition Disorders; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Glycerylphosphorylcholine; Humans; Male; Middle Aged; Parkinson Disease; Pilot Projects; Treatment Outcome

2009

Other Studies

1 other study(ies) available for glycerylphosphorylcholine and Idiopathic Parkinson Disease

ArticleYear
Evidence for a membrane defect in Alzheimer disease brain.
    Proceedings of the National Academy of Sciences of the United States of America, 1992, Mar-01, Volume: 89, Issue:5

    Topics: Aged; Alzheimer Disease; Brain; Brain Chemistry; Choline; Down Syndrome; Glycerylphosphorylcholine; Humans; Huntington Disease; Membrane Lipids; Middle Aged; Parkinson Disease; Phospholipids; Phosphoric Diester Hydrolases; Phosphorylcholine

1992